6919 Kangpei Biotech Announces Board Resolution on 114th Fiscal Year Restricted Stock Grant for Employees
AI Summary (NQ-processed)
Kangpei Biotech's board of directors has resolved to issue 23,000 shares of restricted stock under the 114th fiscal year employee incentive program, with the capital increase benchmark date set as June 26, 115.
AI Analysis
Frequently Asked Questions
Q: Why did Kangpei Biotech issue new shares this time?
A: To strengthen employee incentives and align talent retention with long-term corporate growth.
Q: How many shares were issued?
A: A total of 23,000 restricted shares for employees in fiscal year 114.
Q: What is the capital increase benchmark date?
A: The benchmark date is June 26, 115, adjustable by the chairman if needed.
Q: Is this announcement important for investors?
A: Yes, it signals improved governance and long-term strategic planning.
Q: Are there similar cases in Taiwan's biotech sector?
A: Yes, equity-based incentives are increasingly adopted by listed biotech firms in Taiwan.